CCX832

chemerin receptor 23 (ChemR23) blocker

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Tostes, Rita C: 2 articles (12/2018 - 05/2017)
2.	Alves-Lopes, Rheure: 1 article (12/2018)
3.	Costa, Rafael Menezes da: 1 article (12/2018)
4.	Harvey, Katie Yates: 1 article (12/2018)
5.	Lobato, Nubia Souza: 1 article (12/2018)
6.	Montezano, Augusto Cesar: 1 article (12/2018)
7.	Neves, Karla Bianca: 1 article (12/2018)
8.	Nguyen Dinh Cat, Aurelie: 1 article (12/2018)
9.	Oliveira, Ana Maria de: 1 article (12/2018)
10.	Touyz, Rhian M: 1 article (12/2018)

1.	Esophageal Neoplasms (Esophageal Cancer) 01/01/2014 - "In a xenograft model consisting of OE21 esophageal cancer cells and CAMs, homing of MSCs administered i.v. was inhibited by CCX832. "
2.	Bone Resorption 05/01/2017 - "The increased bone resorption activity induced by chemerin was effectively inhibited by CMKLR1 antagonist (CCX832). "
3.	Body Weight (Weight, Body) 12/01/2018 - "CCX832 treatment of db/db mice decreased body weight, insulin, and glucose levels as well as vascular oxidative stress. "